XLON
ADVT
Market cap327mUSD
Oct 09, Last price
187.50GBP
1D
0.00%
1Q
19.05%
IPO
63.04%
Name
AdvancedAdvT Ltd
Chart & performance
P/E
46.99
P/S
4.06
EPS
0.04
Div yield, %
—
Shrs. gr., 5y
2.92%
Rev. gr., 5y
%
Revenues
61m
+40.69%
Net income
5m
-51.64%
CFO
14m
+51.49%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
AdvancedAdvT Limited engages in the provision of software solutions and platforms in Europe, the United Kingdom, North America, and internationally. It offers business solutions and healthcare compliance; and human capital management. The company also operates financial management software, healthcare intelligence compliance and accreditation software, AI based healthcare intelligence compliance and accreditation software, intelligent process automation software, low code digital platform, resource planning and talent management software, workforce management software, and cloud-based workforce management SaaS products. The company was formerly known as Marwyn Acquisition Company I Limited and changed its name to AdvancedAdvT Limited in March 2021. AdvancedAdvT Limited was incorporated in 2020 and is headquartered in London, the United Kingdom.
Legal address
C/O Conyers Trust Company (BVI) Limited
Commerce House
Wickhams Cay 1
P.O. Box 3140
Road Town VG1110
VG
Commerce House
Wickhams Cay 1
P.O. Box 3140
Road Town VG1110
VG
Headquarters
11 Buckingham Street
London WC2N 6DF
GB
London WC2N 6DF
GB
Previous name
Marwyn Acquisition Company I Limited
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2026‑02 | 2025‑02 | 2024‑02 | 2023‑06 | 2022‑06 | 2021‑06 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||